Ankylosing spondylitis: open trials in South Korea

• NCT07133633

  A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Kyung Hee University Hospital ( Site 2803), Seoul · Hanyang University Seoul Hospital ( Site 2800), Seoul · Kyung Hee University Hosptial at Gangdong ( Site 2802), Seoul

  Registry updated 2026-10-23

• NCT06905288

  Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

  Research · Novartis Pharmaceuticals

  Busan · Gwangju · Jinju

  Registry updated 2026-08-18

• NCT04876781

  Korean Post-marketing Surveillance for Xeljanz XR

  Research · Pfizer

  Pfizer, Seoul

  Registry updated 2026-08-03

• NCT07011979

  SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease

  Research · Seoul National University Hospital

  Seoul National University Hospital, Seoul

  Registry updated 2025-06-10

• NCT01965132

  Korean College of Rheumatology Biologics and Targeted Therapy Registry

  Research · Seoul National University Hospital

  Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

  Registry updated 2024-04-26

• NCT06076083

  Multi-omics Database for Integrative Microbiome Analysis in a Cohort of Korean Patients With Ankylosing Spondylitis

  Research · Tae-Hwan Kim

  Kyung Hee University Medical Center, Seoul · Hanyang University Hospital for Rheumatic Diseases, Seoul

  Registry updated 2023-11-22

All Ankylosing spondylitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error